These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6439093)

  • 1. [Specific immunological profile of candidates for hepatitis A].
    Hainaut J; Dutertre J; Laverdant C
    Ann Med Interne (Paris); 1984; 135(6):444-8. PubMed ID: 6439093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Viral hepatitis A: specific immunological aspects before and after exposure to risk].
    Laverdant C; Hainaut J; Dutertre J
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):167-9. PubMed ID: 6099083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The circulation of the hepatitis A and B viruses in the Somali population].
    Mohamud KB; Aceti A; Mohamed OM; Pennica A; Maalin KA; Biondi R; Hagi MA; Quaranta G; Paparo SB; Celestino D
    Ann Ital Med Int; 1992; 7(2):78-83. PubMed ID: 1334688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superinfection of hepatitis viruses].
    Chen Z; Liu X; Li LY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Oct; 15(5):275-7. PubMed ID: 7532107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
    Cabezas C; Gotuzzo E; Escamilla J; Phillips I
    Rev Gastroenterol Peru; 1994; 14(2):123-34. PubMed ID: 7948940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua.
    Perez OM; Morales W; Paniagua M; Strannegard O
    Am J Trop Med Hyg; 1996 Jul; 55(1):17-21. PubMed ID: 8702016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89].
    Kielland KB; Siebke JC
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):821-4. PubMed ID: 1902331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand.
    Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption].
    Nalpas B; Zylberberg H; Dubois F; Presles MA; Gillant JC; Lienard M; Delemotte B; Bréchot C
    Gastroenterol Clin Biol; 2000 May; 24(5):536-40. PubMed ID: 10891742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
    Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
    Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel.
    Andenaes S; Lie A; Degré M
    Aviat Space Environ Med; 2000 Dec; 71(12):1178-80. PubMed ID: 11439715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
    Thierfelder W; Meisel H; Schreier E; Dortschy R
    Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafamilial transmission of hepatitis B and C viruses in an Italian local health district.
    Del Corno G; Civardi E
    Ann Ig; 2006; 18(4):287-95. PubMed ID: 17063627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.